Does MICAFUNGIN Cause Malignant neoplasm progression? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Malignant neoplasm progression have been filed in association with MICAFUNGIN (Micafungin). This represents 0.5% of all adverse event reports for MICAFUNGIN.
15
Reports of Malignant neoplasm progression with MICAFUNGIN
0.5%
of all MICAFUNGIN reports
13
Deaths
10
Hospitalizations
How Dangerous Is Malignant neoplasm progression From MICAFUNGIN?
Of the 15 reports, 13 (86.7%) resulted in death, 10 (66.7%) required hospitalization, and 3 (20.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MICAFUNGIN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does MICAFUNGIN Cause?
Drug ineffective (608)
Off label use (537)
Product use in unapproved indication (192)
Death (138)
Fungal infection (132)
Multiple organ dysfunction syndrome (129)
Candida infection (127)
Pyrexia (112)
Product use issue (105)
Diarrhoea (104)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which MICAFUNGIN Alternatives Have Lower Malignant neoplasm progression Risk?
MICAFUNGIN vs MICARDIS
MICAFUNGIN vs MICONAZOLE
MICAFUNGIN vs MIDAZOLAM
MICAFUNGIN vs MIDAZOLAM\MIDAZOLAM
MICAFUNGIN vs MIDODRINE